✦ LIBER ✦

PSK1 COST EFFECTIVENESS OF THE USE OF INFLIXIMAB COMPARED TO OTHER BIOLOGICAL AGENTS (BA) IN THE SYSTEMIC TREATMENT OF MODERATE TO SEVERE PSORIASIS

✍ Scribed by M Fonseca; G Araujo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSK1 COST-EFFECTIVENESS ANALYSIS OF AMEV

✍ M Iskedjian; L Barkovsky; O Desjardins; JH Walker; M Dorkalam; N Shear; TR Einar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Efficiency of Biologic Agents in the Tre

✍ A.J. Blasco; P. Lázaro; C. Ferrándiz; A. García-Díez; J. Liso 📂 Article 📅 2009 🏛 Elsevier Science 🌐 Spanish ⚖ 285 KB

PSS14 COST-EFFECTIVENESS OF THE TREATMEN

✍ E Muciño; R Rivas; L Zapata 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PSS9 EFFICIENCY (COST/EFFICACY) OF BIOLO

✍ P Lázaro; AJ Blasco; C Ferrándiz; A García; J Liso 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Biological Agents in the Treatment of Mo

✍ Riveros, B.S.; Souza, T.T.; Godoy, R.R.; Garcia, M.; Gonçalves, P.; Rotta, I.; O 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Effectiveness of Biologic Therapies

✍ Betts, K.A.; Sundaram, M.; Mughal, F.; Yan, S.Y.; Signorovitch, J.; Wang, K.; Wu 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB